Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Malignant Soft Tissue Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT00339118
What this trial is testing

EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children

Who this might be right for
Rhabdomyosarcoma
Sheba Medical Center
Not applicableLooking for participantsNCT06805669
What this trial is testing

This is a Randomized Study of Early Involvement of Palliative Care Along Side Standard Treatment Versus Standard Treatment Alone in Newly Diagnosed Patients With Advanced or Metastatic Soft Tissue Sarcoma (SARQUALITY)

Who this might be right for
Sarcoma
Mount Sinai Hospital, Canada 136
Early research (Phase 1)Study completedNCT03283696
What this trial is testing

Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Eli Lilly and Company 24
Not applicableLooking for participantsNCT05653388
What this trial is testing

Metastatic Leiomyosarcoma Biomarker Protocol

Who this might be right for
Leiomyosarcoma
University of Michigan Rogel Cancer Center 200
Testing effectiveness (Phase 2)Study completedNCT00005066
What this trial is testing

O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma

Who this might be right for
Sarcoma
University of Chicago 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Testing effectiveness (Phase 2)Looking for participantsNCT07291297
What this trial is testing

Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma MetastaticSarcoma, Soft Tissue
Wake Forest University Health Sciences 50
Large-scale testing (Phase 3)Study completedNCT00821860
What this trial is testing

Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant MesotheliomaMetastatic Cancer
Papworth Hospital NHS Foundation Trust 196
Testing effectiveness (Phase 2)Looking for participantsNCT06578624
What this trial is testing

Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Lamassu Bio Inc 70
Large-scale testing (Phase 3)Study completedNCT00354744
What this trial is testing

High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma

Who this might be right for
Sarcoma
Children's Oncology Group 109
Large-scale testing (Phase 3)Study completedNCT00002764
What this trial is testing

Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerKidney CancerMetastatic Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 340
Not applicableStudy completedNCT04690231
What this trial is testing

Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma

Who this might be right for
Effect of DrugToxicity, DrugSecondary Resistance
Peking University People's Hospital 79
Early research (Phase 1)Study completedNCT01231919
What this trial is testing

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT04551430
What this trial is testing

Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma

Who this might be right for
Metastatic Soft-tissue Sarcoma
Washington University School of Medicine 105
Testing effectiveness (Phase 2)Study completedNCT04554836
What this trial is testing

MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the Rectum
TheraOp 6
Early research (Phase 1)Ended earlyNCT05827614
What this trial is testing

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

Who this might be right for
Triple Negative Breast Cancer (TNBC)High Grade Serous Ovarian CarcinomaHigh Grade Endometrial Carcinoma+9 more
Boundless Bio, Inc. 85
Early research (Phase 1)Ended earlyNCT05130255
What this trial is testing

GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2

Who this might be right for
SCLCMalignant MelanomaSarcoma+1 more
Y-mAbs Therapeutics 23
Testing effectiveness (Phase 2)UnknownNCT06384248
What this trial is testing

Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma

Who this might be right for
Unresectable or Metastatic Sarcoma
Letolab 30
Testing effectiveness (Phase 2)Study completedNCT04807816
What this trial is testing

Targeting ATR in Soft-tissue Sarcomas

Who this might be right for
Leiomyosarcoma, Adult
Institut Bergonié 58
Not applicableLooking for participantsNCT03889899
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 30
Next Page